The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Regdanvimab
Australian Public Assessment Report
Device/Product Name
Regkirona
Active ingredients
Regdanvimab
AusPAR Date
Published
Submission Number
PM-2021-04004-1-2
Submission Type
New biological entity
Decision
Approved for provisional registration